Esophageal Cancer Clinical Trial

Clinical Trial Finder Esophageal Cancer Trials

A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

Summary

Participants will a diagnosis of gastroesophageal junction (GEJ) adenocarcinoma and will have either a minimally invasive proximal gastrectomy (MIPG) or a minimally invasive total gastrectomy (MITG) as part of their routine care. Participants with complete a questionnaire 1 month before the surgical procedure and then 1, 3, 6 and 12 months after the surgical procedure.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Able to speak and read English, Spanish, Japanese or Korean
Patients with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
Age ≥ 18

Exclusion Criteria:

Patients with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
Patients with known narcotic dependence, with average daily dose > 5 mg oral morphine equivalent
Subjects deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
Patients who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info